Refreshing the biologic pipeline 2020
- PMID: 33510484
- PMCID: PMC7842168
- DOI: 10.1038/s41587-021-00814-w
Refreshing the biologic pipeline 2020
Abstract
In the absence of face-to-face meetings, FDA and industry implemented regulatory workarounds to maintain drug and biologics approvals. These could be here to stay.
Figures



References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources